Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers
1. Amgen offers Repatha at 60% lower cash price, responding to political pressure. 2. Direct-to-consumer strategies are increasingly adopted by various pharmaceutical companies. 3. TrumpRx.gov aims to lower drug prices through direct sales from manufacturers. 4. AmgenNow allows cash-pay patients to access Repatha affordably, bypassing intermediaries. 5. The industry anticipates more pricing deals impacting drug availability and costs.